logo
Nova Scotia recoups $3.7M in health-transfer clawbacks from Ottawa

Nova Scotia recoups $3.7M in health-transfer clawbacks from Ottawa

CBC06-06-2025
Ottawa has paid Nova Scotia several million dollars in health transfers that were previously withheld because of people paying out of pocket for private MRIs and ultrasounds.
According to the federal government, no one in Canada should pay for medically necessary diagnostic imaging services, and it's been clawing back money from Nova Scotia and other provinces for allowing it to happen.
However, Nova Scotia and Ottawa have come to an agreement that recently resulted in a reimbursement of $3.79 million — the total amount clawed back over the past three years. The payment was finalized in March.
"It's been a long time coming," said Katherine Fierlbeck, a professor of political science at Dalhousie University who studies health policy. She noted many other provinces have already made arrangements to reduce or eliminate privately funded medical imaging to have their health transfers reimbursed.
Fierlbeck said she has a long list of questions about the details of the agreement, some of which she's hoping will be answered in Health Canada's annual report on transfer payments.
The report is typically tabled in Parliament each March, but the House wasn't sitting from the start of January to the end of May — the result of a prorogation and then the federal election. The report has yet to be tabled since the new session began last week.
Health Canada released the reimbursement numbers to CBC News on request, along with a brief explanation.
Contract with private clinic
A spokesperson for Health Canada said the key reason for the reimbursement is "efforts taken by Nova Scotia to eliminate patient charges at the private clinic."
The private clinic they refer to is Healthview, which offers MRIs and ultrasounds. Nova Scotia Health (NSH) signed a contract with the Halifax imaging clinic last May to send some patients there at the public expense.
A spokesperson for NSH said 2,278 MRIs and 585 ultrasounds were publicly funded at Healthview in the first year of the five-year, $7.6-million agreement. Patients who NSH sends to Healthview are triaged in the same way as patients who go to public clinics.
Privately funded imaging continues
But the contract with Healthview does not entirely eliminate cases of patients paying for medically necessary imaging.
Healthview still accepts patients who want to pay to jump the queue, and at least two other private clinics in Halifax do the same.
Wosler Diagnostics opened last summer, offering ultrasound only, and Why Wait Imaging opened earlier this year, offering ultrasounds and MRIs. NSH confirmed it does not have contracts with either of these clinics.
Fierlbeck said this is hard to reconcile with the fact the province received a full reimbursement of health transfer clawbacks.
WATCH | Why Nova Scotia was losing out on health transfer payments:
Why N.S. is losing out on health transfers as private medical imaging grows
5 months ago
Duration 2:18
With long waits for ultrasounds and MRIs, some Nova Scotians are paying to get care sooner at private clinics. But Ottawa says those services should be publicly funded and it's punishing Nova Scotia for allowing patients to pay. Taryn Grant has the story.
"If it's only partial coverage, I would have thought that the ministry would say 'OK, partial coverage, we'll give you partial reimbursement,'" Fierlbeck said.
She said covering some services at private clinics — but not all — makes for a "thinly veiled two-tier system."
The Nova Scotia Department of Health and Wellness would not make anyone available for an interview.
Health authority working on imaging backlogs
The underlying issue that's pushing many Nova Scotians to seek private medical imaging is a backlog in the public health-care system, with some people waiting months or years for MRIs and ultrasounds.
Dr. Tim Mailman said the problem is complex and has been years in the making, but Nova Scotia Health is "laser-focused" on improvements.
Mailman, senior medical director of the diagnostics and therapeutic services network, said the main bottleneck is staffing; there's a shortage of imaging technologists.
"Let's use MRI as an example," he said in an interview earlier this year. "If we were able to run our current MRIs across the province [for] extended hours, we have enough MRIs to meet the demand."
Mailman said there's a "complex workforce strategy" in the works to address that issue.
Additionally, Mailman said the health authority is working on a central intake system to streamline booking. He said he expects it will reduce duplication and no-shows, and ultimately shorten wait times. The health authority is expecting the system to come online this summer.
Mailman said the health authority is also working on training and support for clinicians to make sure they're sending patients for the most appropriate type of imaging.
"As a provider myself, I can tell you it's not always easy … I still call my phone-a-friend radiologist to say, 'With this specific situation, should I be asking for a CT? Should I be asking for an MRI?'
"It's not policing the resources, it's working with providers," he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump
Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump

Globe and Mail

timean hour ago

  • Globe and Mail

Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump

U.S. drugmaker Eli Lilly & Co. has increased prices of its popular diabetes and anti-obesity drugs in Canada as it responds to pressure from the Trump administration to lower prices in the United States and raise them elsewhere. The company also announced it is sharply raising prices in Britain to match those in other European markets. The moves make the company one of the most high-profile so far to respond U.S. President Donald Trump's direction to rebalance global drug prices. 'Lilly supports the administration's goal of keeping the United States the world's leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries,' the company said Thursday in an unsigned statement. 'This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the U.S.' Is working out necessary in the age of Ozempic? Lilly is raising the list price in Britain for Mounjaro, its type 2 diabetes treatment, by 170 per cent, Reuters reported. The market for weight-loss drugs has exploded in recent years, led by Novo Nordisk's Ozempic and Wegovy, which are prescribed for diabetes and obesity, respectively. Ozempic earned $2.5-billion at retail pharmacies in Canada in 2024, according to data from industry broker IQVIA, nearly triple the next best-selling drug. Lilly introduced Mounjaro in Canada in late 2023. It was originally sold in single-dose vials (taken weekly) at a wholesale price of around $80. It is sold in six different dosages. The company then introduced a four-dose format called Kwikpen in January of 2025 and then a Kwikpen form of Zepbound, for obesity, in June. At the same time, it raised the prices of the single-dose vials to be in line with those of the Kwikpen and lowered production of the vials, leading to low inventories across the country. Cubic Health, a company that analyzes drug prices for insurance plan sponsors, said in a recent note to its clients that the annual cost of taking Mounjaro has more than doubled for high dosages since it first came to Canada. Cubic said the wholesale price for the Kwikpen now ranges from $387 to $773 depending on dosage, which can lead to an annual cost of more than $10,000. (Individual costs can vary depending on pharmacy, insurance coverage, discounts and other factors.) 'Vials were only intended as a short-term solution until a multidose pen became available to the Canadian market,' Lilly spokesman Ethan Pigott said in a statement. 'Lilly will continue to support patients already using the vial format, but the KwikPen device will be prioritized go-forward for its supply sustainability, ease of use and multidose presentation.' He also said discussion of price should include multiple factors. 'Both Mounjaro and Zepbound are priced to reflect the value they can provide to individuals, health systems, and society in treating type 2 diabetes and obesity,' Mr. Pigott said. Mounjaro and Zepbound are covered by some private insurance plans, depending on individual plan designs. The drugs are not yet covered by any public insurance plans, which require going through national bodies that assess drugs and negotiate prices. Lilly had started an application to Canada's Drug Agency to have Mounjaro (also known as tirzepatide) assessed in 2022, but a spokesperson for the CDA said the submission was cancelled because of paperwork deficiencies. Earlier: Generic version of Ozempic, Wegovy to launch in Canada by Hims & Hers Mr. Pigott said Lilly is finalizing plans to resubmit Mounjaro, along with Zepbound, to the CDA 'in 2025.' While the average cost of these drugs in Canada is up, it is still a little short of prices in the U.S. The wholesale price of Zepbound in the U.S. is US$1,086, according to Lilly's website. It also offers direct-to-consumer sales in the U.S. at prices that range from US$349 to US$1,049, depending on dosage. Lilly has not yet launched direct sales in Canada. Drug prices in the U.S. are, on average, more than three times those in Canada. Mr. Trump has repeatedly mentioned that statistic as he admonishes drug companies for their prices. In May, he signed an executive order that directed Health Secretary Robert F. Kennedy Jr. to work with drug companies on 'most favoured nation' pricing for pharmaceuticals. Trump says new order will lower U.S. drug prices and increase them everywhere else Two weeks ago, Mr. Trump sent letters to 17 drug companies – including Lilly – telling them to increase prices in non-U.S. markets to make up for lower revenue in the U.S. The administration has also launched a national-security investigation of the sector that could lead to tariffs, which Mr. Trump has mused could be as high as 200 per cent. In Lilly's statement on Thursday, the company said it does not support tariffs. 'Broad tariffs would raise costs, limit patient access and undermine American leadership, especially for companies already investing heavily in domestic manufacturing,' the company said.

Dairy Queen Blizzards help raise funds for CHEO on Miracle Treat Day
Dairy Queen Blizzards help raise funds for CHEO on Miracle Treat Day

CTV News

timean hour ago

  • CTV News

Dairy Queen Blizzards help raise funds for CHEO on Miracle Treat Day

For 13-year-old Lu Oudhoff, a Dairy Queen Blizzard comes with a serving of hope. 'It's really great that we get to help them by eating ice cream, because ice cream is awesome,' said Lu. Lu knows firsthand what CHEO can do for young people. 'I had a depressive episode, and I was suffering anxiety. CHEO sort of helped me through it and made it so that I wasn't feeling so alone.' It's a feeling echoed by Lu's mom, Rose Spangers. 'For Lu to have been able to turn something that was really a very tough period for them into something that empowers them and helps them give something back to the hospital that has been such an amazing support for them throughout their mental health journey, that's been amazing,' Spangers said. This year marks 41 years of partnership between Dairy Queen and the Children's Miracle Network, with more than $55 million raised for Canadian hospitals since 1984. Miracle Treat Day Ottawa Dairy Queen stores are supporting CHEO on Miracle Treat Day. Aug. 14, 2025. 'Every year, Miracle Treat Day is held across the country as part of Children's Miracle Network and Dairy Queen locations are kind enough to donate their net proceeds from Blizzard sales to the local children's hospital,' said Steve Read, CHEO Foundation president and CEO. Supporting CHEO is something many in the community are proud to do. 'We work in construction, and we do this every year for the guys,' said DQ customer Donalda Tryon, who ordered 15 Blizzards for her crew. 'We do it at Camp Tay for Tim Hortons. We do it on McDonald's day as well, so it just helps out everyone.' Miracle Treat Day Proceeds from Dairy Queen Blizzards on Miracle Treat Day are donated to children's hospitals in Canada. (Dave Charbonneau/CTV News Ottawa) 'I think CHEO, in our community, to have that level of care for kids, we're so fortunate to have so close by,' said DQ customer Rebecca Laginski. This year, more than 660 Dairy Queen stores are supporting 13 children's hospital foundations across the country. 'This helps us give back to the community in the best way possible. To raise funds for the children, the future of our country. And raise money for all the Children's Miracle Network hospitals,' said Noman Hussain, Dairy Queen Eastern Ontario business consultant. Miracle Treat Day Supporting CHEO on Miracle Treat Day is as easy as buying a Dairy Queen Blizzard. (Dave Charbonneau/CTV News Ottawa) As for Lu, making a difference has never been so sweet. 'We literally just buy an ice cream and then bam, we're helping CHEO.'

Recovery Acres Calgary Society hoping to add more beds with annual fundraiser
Recovery Acres Calgary Society hoping to add more beds with annual fundraiser

CTV News

timean hour ago

  • CTV News

Recovery Acres Calgary Society hoping to add more beds with annual fundraiser

Recovery Acres Calgary Society is hoping an upcoming fundraiser will help dozens of women waiting for treatment. Officials at a Calgary addictions recovery centre are hoping an upcoming fundraiser will help dozens of women waiting for treatment. Recovery Acres Calgary Society (RACS) is holding its 28th annual Charity Golf Tournament at Wintergreen Golf & Country Club in Bragg Creek on Monday, Aug. 18. Proceeds from the tournament will go toward an expansion that includes a new 26-bed women's residential facility, part of a multi-phase capital plan that would ultimately replace and upgrade all three of its buildings. The tournament has raised more than $1.5 million to support the centre's programs and upgrades over nearly three decades. For peer-support worker Makaela Smith, the expansion could be life saving for women still waiting for treatment. Smith will mark three years sober in December after completing Recovery Acres' program in 2022. 'I am a person in recovery myself,' she said. 'I went through the Recovery Acres program and it was pivotal for me to have this place; a place to heal, to learn the tools to live life.' 'Because of Recovery Acres, I am a mother to my four beautiful children today. I am an active member in society and a person in recovery, and that's a result of this place. This is what Recovery Acres does. It reunites families.' Smith says the need is urgent. 'People are dying. That is the result of these long wait lists,' she said. 'Women are dying, men are dying; there's not enough beds within the community. The wait list is not manageable.' Recovery Acres executive director Stian Rorstad says the women's program began with eight beds in 2022 and filled to capacity quickly. 'On our opening day, we had 50 women on our wait list with only eight beds to help them,' he said. 'We still have wait lists of dozens of women to get into this program. A person could wait upwards to six weeks at times in order to be able to access a bed.' 'Asking for help, that's a huge first step,' Rorstad added. 'But it's also very important to strike when that iron is hot, and the real danger there is that people can die while on a wait list.' Fund development manager Jason Quilley says the tournament's proceeds will be directed to the women's building. He notes that roughly $6 million is needed to upgrade the Recovery Acres Society facility located at 1835 27 Ave. S.W. Design renderings show a three-phase plan: first, a new 26-bed women's facility. Second, a 40-bed men's building to replace the old one, and third, renovating the historic 1835 house into shared program and resource spaces. 'I owe my life to this place, and it's my purpose and my passion to give back,' said Quilley, who completed the Recovery Acres program himself. 'Sometimes the phone can seem like it weighs 4,000 pounds, and it's hard to ask for help, but if you reach out someone will answer, someone will be there for you, and we want to continue being there for those in need.' Urgent need underscored by opioid crisis The fundraiser comes as Alberta continues to report hundreds of opioid-related deaths each year. In 2023, Alberta recorded 1,873 opioid-related deaths, which was a record-breaking year. In 2024, those numbers decreased significantly to 1,182, but 405 deaths have occurred from January to April 2025 so far. Calgary alone recorded 626 deaths in 2023, 284 in 2024 and 62 from January to April 2025. The numbers are staggering, but people like Smith say real people are behind those figures and those who seek help deserve a new lease on life. 'The opposite of addiction is connection,' said Smith. 'Addiction is lonely, but in recovery we find community, we find people who care and there is a whole community waiting to help.' Recovery Acres Calgary since 1973 has supported more than 16,000 people in receiving help at its facility. Registration, sponsorships, prize donations and direct contributions to the expansion can be made through the society's website or by contacting the organization.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store